Advertisement
Original research| Volume 18, ISSUE 1, P114-118, January 2015

Download started.

Ok

MCT1 A1470T: A novel polymorphism for sprint performance?

Published:January 31, 2014DOI:https://doi.org/10.1016/j.jsams.2013.12.008

      Abstract

      Objectives

      The A1470T polymorphism (rs1049434) in the monocarboxylate (lactate/pyruvate) transporter 1 gene (MCT1) has been suggested to influence athletic performance in the general population. We compared genotype distributions and allele frequencies of the MCT1 gene A1470T polymorphism between endurance athletes, sprint/power athletes and matched controls. We also examined the association between the MCT1 A1470T and the athletes’ competition level (‘elite’ and ‘national’ level).

      Design

      The study involved endurance athletes (n = 112), sprint/power athletes (n = 100), and unrelated sedentary controls (n = 621), all Caucasians.

      Methods

      Genomic DNA was extracted from buccal epithelium using a standard protocol. We conducted Fisher's exact tests and multinomial logistic regression analyses to assess the association between MCT1 genotype and athletic status/competition level.

      Results

      Sprint/power athletes were more likely than controls to possess the minor T allele (TT genotype compared to the AA [p < 0.001]; TT or AT compared to the AA [p = 0.007]; TT compared to both AA and AT genotypes [p < 0.001]). Likewise, sprint/power athletes were more likely than endurance athletes to have the TT genotype compared to the AA (p = 0.029) and the TT compared to both AA and AT genotypes (p = 0.027). Furthermore, elite sprint/power athletes were more likely than national-level athletes to have the TT genotype compared to the AA (p = 0.044), and more likely to have the TT genotype compared to both AA and AT genotypes (recessive model) (p = 0.045).

      Conclusions

      The MCT1 TT genotype is associated with elite sprint/power athletic status. Future studies are encouraged to replicate these findings in other elite athlete cohorts.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Science and Medicine in Sport
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eynon N.
        • Ruiz J.R.
        • Oliveira J.
        • et al.
        Genes and elite athletes: a roadmap for future research.
        J Physiol. 2011; 589: 3063-3070
        • De Moor M.H.
        • Spector T.D.
        • Cherkas L.F.
        • et al.
        Genome-wide linkage scan for athlete status in 700 British female DZ twin pairs.
        Twin Res Hum Genet. 2007; 10: 812-820
        • Bouchard C.
        • Sarzynski M.A.
        • Rice T.K.
        • et al.
        Genomic predictors of the maximal O(2) uptake response to standardized exercise training programs.
        J Appl Physiol. 2011; 110: 1160-1170
        • Calvo M.
        • Rodas G.
        • Vallejo M.
        • et al.
        Heritability of explosive power and anaerobic capacity in humans.
        Eur J Appl Physiol. 2002; 86: 218-225
        • Williams A.G.
        • Folland J.P.
        Similarity of polygenic profiles limits the potential for elite human physical performance.
        J Physiol. 2008; 586: 113-121
        • Eynon N.
        • Alves A.J.
        • Meckel Y.
        • et al.
        Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance?.
        Metabolism. 2010; 59: 861-865
        • Mikami E.
        • Fuku N.
        • Murakami H.
        • et al.
        ACTN3 R577X genotype is associated with sprinting in elite Japanese athletes.
        Int J Sports Med. 2013; ([Epub ahead of print])
        • Eynon N.
        • Duarte J.A.
        • Oliveira J.
        • et al.
        ACTN3 R577X polymorphism and Israeli top-level athletes.
        Int J Sports Med. 2009; 30: 695-698
        • Alfred T.
        • Ben-Shlomo Y.
        • Cooper R.
        • et al.
        ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies.
        Hum Mutat. 2011; 32: 1008-1018
        • Eynon N.
        • Ruiz J.R.
        • Femia P.
        • et al.
        The ACTN3 R577X polymorphism across three groups of elite male European athletes.
        PLoS ONE. 2012; 7: e43132
        • Yang N.
        • MacArthur D.G.
        • Gulbin J.P.
        • et al.
        ACTN3 genotype is associated with human elite athletic performance.
        Am J Hum Genet. 2003; 73: 627-631
        • Amir O.
        • Amir R.
        • Yamin C.
        • et al.
        The ACE deletion allele is associated with Israeli elite endurance athletes.
        Exp Physiol. 2007; 92: 881-886
        • Di Cagno A.
        • Sapere N.
        • Piazza M.
        • et al.
        ACE and AGTR1 polymorphisms in elite rhythmic gymnastics.
        Genet Test Mol Biomarkers. 2013; 17: 99-103
        • Bishop D.
        • Edge J.
        • Thomas C.
        • et al.
        High-intensity exercise acutely decreases the membrane content of MCT1 and MCT4 and buffer capacity in human skeletal muscle.
        J Appl Physiol. 2007; 102: 616-621
        • Bonen A.
        The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
        Eur J Appl Physiol. 2001; 86: 6-11
        • Thomas C.
        • Bishop D.J.
        • Lambert K.
        • et al.
        Effects of acute and chronic exercise on sarcolemmal MCT1 and MCT4 contents in human skeletal muscles: current status.
        Am J Physiol Regul Integr Comp Physiol. 2012; 302: R1-R14
        • Dubouchaud H.
        • Butterfield G.E.
        • Wolfel E.E.
        • et al.
        Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle.
        Am J Physiol Endocrinol Metab. 2000; 278: E571-E579
        • Pilegaard H.
        • Domino K.
        • Noland T.
        • et al.
        Effect of high-intensity exercise training on lactate/H+ transport capacity in human skeletal muscle.
        Am J Physiol. 1999; 276: E255-E261
        • Wilson M.C.
        • Jackson V.N.
        • Heddle C.
        • et al.
        Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3.
        J Biol Chem. 1998; 273: 15920-15926
        • McCullagh K.J.
        • Poole R.C.
        • Halestrap A.P.
        • et al.
        Chronic electrical stimulation increases MCT1 and lactate uptake in red and white skeletal muscle.
        Am J Physiol. 1997; 273: E239-E246
        • Bonen A.
        • McCullagh K.J.
        • Putman C.T.
        • et al.
        Short-term training increases human muscle MCT1 and femoral venous lactate in relation to muscle lactate.
        Am J Physiol. 1998; 274: E102-E107
        • Juel C.
        Lactate-proton cotransport in skeletal muscle.
        Physiol Rev. 1997; 77: 321-358
        • Merezhinskaya N.
        • Fishbein W.N.
        • Davis J.I.
        • et al.
        Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport.
        Muscle Nerve. 2000; 23: 90-97
        • Cupeiro R.
        • Benito P.J.
        • Maffulli N.
        • et al.
        MCT1 genetic polymorphism influence in high intensity circuit training: a pilot study.
        J Sci Med Sport. 2010; 13: 526-530
        • Little J.
        • Higgins J.P.
        • Ioannidis J.P.
        • et al.
        Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement.
        Hum Genet. 2009; 125: 131-151
        • Eynon N.
        • Hanson E.D.
        • Lucia A.
        • et al.
        Genes for elite power and sprint performance: ACTN3 leads the way.
        Sports Med. 2013; 43: 803-817
        • Ruiz J.R.
        • Arteta D.
        • Buxens A.
        • et al.
        Can we identify a power-oriented polygenic profile?.
        J Appl Physiol. 2010; 108: 561-566
        • Eynon N.
        • Ruiz J.R.
        • Meckel Y.
        • et al.
        Mitochondrial biogenesis related endurance genotype score and sports performance in athletes.
        Mitochondrion. 2011; 11: 64-69
        • Maciejewska-Karlowska A.
        • Hanson E.
        • Sawczuk M.
        • et al.
        Genomic haplotype within the peroxisome proliferator-activated receptor delta (PPARD) gene is associated with elite athletic status.
        Scand J Med Sci Sports. 2013; ([Epub ahead of print])